Home › Compare › LTRPB vs MRK

LTRPB vs MRK: Dividend Comparison 2026

LTRPB yields 796.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LTRPB wins by $2681936.37M in total portfolio value
10 years
LTRPB
LTRPB
● Live price
796.81%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2681936.43M
Annual income
$2,150,922,153,910.93
Full LTRPB calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LTRPB vs MRK

📍 LTRPB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLTRPBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LTRPB + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LTRPB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LTRPB
Annual income on $10K today (after 15% tax)
$67,729.08/yr
After 10yr DRIP, annual income (after tax)
$1,828,283,830,824.29/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LTRPB beats the other by $1,828,283,822,495.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LTRPB + MRK for your $10,000?

LTRPB: 50%MRK: 50%
100% MRK50/50100% LTRPB
Portfolio after 10yr
$1340968.24M
Annual income
$1,075,461,081,854.53/yr
Blended yield
80.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LTRPB
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$21.50
+8465.7% upside vs current
Range: $15.00 — $28.00
Altman Z
-0.4
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LTRPB buys
0
MRK buys
0
No recent congressional trades found for LTRPB or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLTRPBMRK
Forward yield796.81% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$2681936.43M ✓$56.8K
Annual income after 10y$2,150,922,153,910.93 ✓$9,798.13
Total dividends collected$2639916.21M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$21.50$128.54 ✓

Year-by-year: LTRPB vs MRK ($10,000, DRIP)

YearLTRPB PortfolioLTRPB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$90,381$79,681.27$11,206$366.19+$79.2K → LTRPB
2$769,764$673,055.63$12,650$502.35+$757.1K → LTRPB
3$6,180,948$5,357,301.45$14,407$694.19+$6.17M → LTRPB
4$46,816,763$40,203,148.48$16,585$967.82+$46.80M → LTRPB
5$334,685,846$284,591,909.30$19,342$1,363.89+$334.67M → LTRPB
6$2,259,519,295$1,901,405,440.15$22,913$1,947.19+$2259.50M → LTRPB
7$14,414,602,874$11,996,917,227.94$27,662$2,823.89+$14414.58M → LTRPB
8$86,951,037,181$71,527,412,105.33$34,159$4,173.35+$86951.00M → LTRPB
9$496,275,022,457$403,237,412,673.28$43,337$6,308.80+$496274.98M → LTRPB
10$2,681,936,427,939$2,150,922,153,910.93$56,776$9,798.13+$2681936.37M → LTRPB

LTRPB vs MRK: Complete Analysis 2026

LTRPB — Stock

Liberty TripAdvisor Holdings, Inc., through its subsidiaries, operates travel guidance platform that connects travelers with travel partners. The company operates through two segments, Hotels, Media & Platform, and Experiences & Dining. Its travel platform provides content, price comparison tools, and online reservation and related services for destinations, accommodations, travel activities and experiences, and restaurants. The company owns and operates a portfolio of online travel guidance brands and businesses, which offers travel-planning and trip-taking resources in the travel industry; and provides click-based, display-based, and subscription-based advertising services. It also operates Viator, a website that offers research, book, and experience activities and attractions in travel destinations; and TheFork, an online restaurant reservations platform. The company was incorporated in 2013 and is headquartered in Englewood, Colorado.

Full LTRPB Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LTRPB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LTRPB vs SCHDLTRPB vs JEPILTRPB vs OLTRPB vs KOLTRPB vs MAINLTRPB vs JNJLTRPB vs ABBVLTRPB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.